Integral Diagnostics Limited (ASX:IDX)

Market Cap	954.14M
Revenue (ttm)	627.22M
Net Income (ttm)	4.67M
Shares Out	372.71M
EPS (ttm)	0.02
PE Ratio	169.95
Forward PE	19.91
Dividend	0.07 (2.52%)
Ex-Dividend Date	Aug 29, 2025

Volume	993,636
Average Volume	1,346,350
Open	2.600
Previous Close	2.580
Day's Range	2.540 - 2.600
52-Week Range	1.910 - 3.180
Beta	0.17
RSI	47.09
Earnings Date	Nov 25, 2025

About Integral Diagnostics

Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand. The company offers magnetic resonance imaging, positron emission tomography, computed tomography mammography, interventional radiology, ultrasound, and radiography, such as x-ray and EOS. Integral Diagnostics Limited was founded in 1967 and is headquartered in Melbourne, Australia.

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1967
• Employees: 3,025
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: IDX